Inter‐Ethnic Differences in the Efficacy and Safety of Tyrosine Kinase Inhibitors Used in Oncology: Insights From Phase 3 Clinical Trials

ABSTRACT Differences in the efficacy and safety of tyrosine kinase inhibitors (TKIs) have been observed across ethnic/ancestry subpopulations (previously reviewed to 2017). With an expanding number of TKIs approved since that time, an updated review of TKI response across ethnic/ancestry subpopulati...

Full description

Saved in:
Bibliographic Details
Main Authors: Nicki M. Kyriacou, Annette S. Gross, Andrew J. McLachlan
Format: Article
Language:English
Published: Wiley 2025-05-01
Series:Clinical and Translational Science
Subjects:
Online Access:https://doi.org/10.1111/cts.70224
Tags: Add Tag
No Tags, Be the first to tag this record!